Sfoglia per Rivista
International Registry of rare bleeding disorders (RBD)
2004 F. Peyvandi, M. Spreafico, M. Menegatti, I.M. Garagiola, L. Tagliabue, P.M. Mannucci
International survey of attitudes towards secondary prophylaxis with recombinant factor VIIa in haemophilia A patients with inhibitors
2009 P. Mannucci, P.A. Palhares de Miranda
An international survey to inform priorities for new guidelines on von Willebrand disease
2020 M.A. Kalot, M. Al-Khatib, N.T. Connell, V. Flood, R. Brignardello-Petersen, P. James, R.A. Mustafa, R. Abdul-Kadir, B. Ameer, A. Arapshian, M.C. Ozelo, S. Couper, J. Grow, J. Eikenboom, N. Giraud, S. Haberichter, V. Jacobs-Pratt, J. Di Paola, B.A. Konkle, P. Kouides, M. Laffan, M. Lavin, F. Leebeek, C. Mclintock, S. Mcrae, R. Montgomery, J.S. O'Donnell, J.E. Sadler, N. Scappe, R.F. Sidonio, F. Stufano, A. Tosetto, A.C. Weyand, J. Castano, M. El Ekiaby, J. Graham, S. Halimeh, R. Kunkle, F. Peyvandi, R.M. Plovnick, E. Riker, F. Robinson, M.W. Skinner, W. Nichols
Involvement of the IgE-basophil system and mild complement activation in haemophilia B with anti-factor IX neutralizing antibodies and anaphylaxis
2017 M. Cugno, M.E. Mancuso, A. Tedeschi, E. Santagostino, M. Lorini, V. Carbonelli, F. Peyvandi, P.M. Mannucci
An Italian experience
2008 S. von Mackensen, A. Gringeri, L. Scalone, F. Borghetti, L. Mantovani
Italian guidelines for the diagnosis and treatment of patients with haemophilia and inhibitors
2005 A. Gringeri, P.M. Mannucci
Italian Registry of Haemophilia and Allied Disorders : objectives, methodology and data analysis
2008 A. Iorio, E. Oliovecchi, M. Morfini, P.M. Mannucci, Association of Italian Hemophilia Centres Directors
Joint WFH-ISTH session : issues in clinical trial design
2014 F. Peyvandi, A. Farrugia, A. Iorio, N.S. Key, A. Srivastava
Kreuth IV: European consensus proposals for treatment of haemophilia with coagulation factor concentrates
2017 P.L.F. Giangrande, F. Peyvandi, B. O'Mahony, M.-. Behr-Gross, A. Hilger, W. Schramm, P.M. Mannucci
Laboratory issues in bleeding disorders
2006 D. Lillicrap, S.C. Nair, A. Srivastava, F. Rodeghiero, I. Pabinger, A.B. Federici
Long-term prophylaxis in severe factor VII deficiency
2015 S.M. Siboni, E. Biguzzi, C. Mistretta, I. Garagiola, F. Peyvandi
Low thrombin generation during major orthopaedic surgery fails to predict the bleeding risk in inhibitor patients treated with bypassing agents
2016 M.E. Mancuso, V. Chantarangkul, M. Clerici, M.R. Fasulo, L. Padovan, E. Scalambrino, F. Peyvandi, A. Tripodi, E. Santagostino
Low-rate of complications after a long-term use of ateriovenous fistula (AVF) in hemophilic children
2008 E. Santagostino, M.E. Mancuso, A. Gringeri, S.M. Siboni, P.M. Mannucci
Management of bleeding disorders in adults
2012 F. Peyvandi, R. Klamoroth, M. Carcao, A.B. Federici, G. Di Minno, V. Jimenez-Yuste, E.C. Rodriguez Merchan
Management of orthopaedic surgery in rare bleeding disorders
2014 S.M. Siboni, E. Biguzzi, G. Pasta, P.M. Mannucci, C. Mistretta, N.N. Fantini, L.P. Solimeno, F. Peyvandi
Management of pregnancy in type 2B von Willebrand disease: case report and literature review
2015 E. Biguzzi, S.M. Siboni, M.W. Ossola, B. Zaina, A.C. Migliorini, F. Peyvandi
Minimal residual FXIII coagulant activity to prevent spontaneous major bleeding, on behalf of the PRO-RBDD group
2016 F. Peyvandi, R. Palla, M. Menegatti, P. Bucciarelli, M. Boscarino, L. Muszbek
Molecular diagnosis of von Willebrand disease
2017 L. Baronciani, A. Goodeve, F. Peyvandi
Molecular evaluation of a naturally occuring mutation on Factor X gene (Gly222Asp) causing severe FX deficiency
2004 F. Peyvandi, M. Menegatti, K. Kavakli, M. Karimi, P.M. Mannucci
Molecular investigation of 41 patients affected by coagulation factor XI deficiency
2018 V. Rimoldi, E.M. Paraboschi, M. Menegatti, F. Peyvandi, O. Salomon, S. Duga, R. Asselta
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile